Home About us Articles Multimedia Search Instructions Login 
IF 2017: 1.596 (® Clarivate Analytics)
Total Cites: 7606
Q2 in Medicine, General & Internal
Follow Us
Follow Us
  • Users Online: 1478
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy

Li Mu-Xing, Bi Xin-Yu, Zhao Hong, Huang Zhen, Han Yue, Zhao Dong-Bin, Zhao Jian-Jun, Cai Jian-Qiang

Year : 2016| Volume: 129| Issue : 5 | Page no: 586-593

   This article has been cited by
1 Clinical importance of DNA repair in sporadic colorectal cancer
Gustavo A. Laporte,Natalia M. Leguisamo,Antonio N. Kalil,Jenifer Saffi
Critical Reviews in Oncology/Hematology. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 The polymorphisms of miRNA-binding site in MLH3 and ERCC1 were linked to the risk of colorectal cancer in a case-control study
Qianye Zhang,Xiao Zheng,Xiaoxia Li,Deyu Sun,Ping Xue,Guopei Zhang,Mingyang Xiao,Yuan Cai,Cuihong Jin,Jinghua Yang,Shengwen Wu,Xiaobo Lu
Cancer Medicine. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options
Daniela Rodrigues,Adhemar Longatto-Filho,Sandra F. Martins
BioMed Research International. 2016; 2016: 1
[Pubmed]  [Google Scholar] [DOI]


Read this article